WELTRUZA™ receives FDA Approval • View webcast replay

Events Investors

Videoconference • Collaboration with AbbVie (French)

By MedincellApril 17, 2024July 15th, 2025No Comments

Download PDF presentation

Download press release

Previous PostMedincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies
Next Post[Replay] Videoconference • Collaboration with AbbVie (French)